During the past decade, Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" #1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are "Esophageal Squamous Cell Carcinoma" (1 trials) and "Small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" in a lesser frequency.

Most popular intervention types in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Carboplatin" (1 trials), "Etoposide" (1 trials) and "Lurbinectedin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".